Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> FOOD AND DRUG ADMINISTRATION Latest News

NOV 21, 2014 - Yahoo! News

A Must Read - Share

FDA approves Purdue's painkiller that can reduce abuse

(This version of the Nov. 20 story, corrects final paragraph to show Embeda treats pain, not opioid dependence) (Reuters)- The U.S. Food and Drug Administration has approved a long-acting narcotic painkiller with abuse-resistant properties made by Purdue Pharma L.P., the agency said on Thursday. The FDA approved the once-daily drug, Hysingla ER, with the expectation that it will reduce, though ...

Tags: FDA approves Purdue's painkiller that can reduce abuse,  Food And Drug Administration Latest News

NOV 21, 2014 - New York Times

A Must Read - Share

F.D.A. Approves Hysingla, a Powerful Painkiller

The Food and Drug Administration on Thursday approved a long-acting opioid painkiller that contains pure hydrocodone, which some addiction experts fear will be abused.

Tags: F.D.A. Approves Hysingla, a Powerful Painkiller,  Food And Drug Administration Latest News

NOV 20, 2014 - Washington Times

A Must Read - Share

FDA approves new, hard-to-abuse hydrocodone pill

WASHINGTON (AP) - Federal health regulators have approved the first hard-to-abuse version of the painkiller hydrocodone, offering an alternative to a similar medication that has been widely criticized for lacking such safeguards. The Food and Drug Administration approved Purdue Pharma's Hysingla ER, for patients with severe, round-the-clock pain ...

Tags: FDA approves new, hard-to-abuse hydrocodone pill,  Food And Drug Administration Latest News

NOV 19, 2014 - Yahoo! News

A Must Read - Share

Royalty Pharma buys royalties on Vertex Pharma drugs for $3.3 billion

(Reuters) - Pharmaceutical investment firm Royalty Pharma said it would buy royalties on Vertex Pharmaceuticals Inc's cystic fibrosis treatments from Cystic Fibrosis Foundation for $3.3 billion in cash. Vertex's cystic fibrosis drug, Kalydeco, was approved by the U.S. Food and Drug Administration in January 2012. Vertex co-developed the drug with an affiliate of the Cystic Fibrosis Foundation. The foundation plans ...

Tags: Royalty Pharma buys royalties on Vertex Pharma drugs for $3.3 billion,  Food And Drug Administration Latest News

NOV 18, 2014 - Family Practice News

A Must Read - Share

Alemtuzumab, two-course infusion, approved for relapsing MS

Alemtuzumab, administered in two intravenous infusions over several days 1 year apart, has been approved by the Food and Drug Administration for patie

Tags: Alemtuzumab, two-course infusion, approved for relapsing MS,  Food And Drug Administration Latest News